Prof Wei Duan

In situ imaging miRNAs using multifunctional linear DNA nanostructure

H Xu, M Lin, Y Zheng, X Fang, X Huang, Q Huang, J Xu, W Duan, J Wei, L Jia

(2023), Vol. 253, Talanta, Netherlands, C1

The roles EpCAM plays to enhance the malignancy of gastric cancer

X Zhao, R Zhao, Y Feng, Z Qiu, X Bai, D Zhang, Y Zhou, H Fang, N Liu, L Chen, C Jia, Y Yuan, X Li, W Duan, G Nie, Y Hou

(2023), Journal of Cancer Research and Clinical Oncology, C1

Zwitterionic Block Copolymer Prodrug Micelles for pH Responsive Drug Delivery and Hypoxia-Specific Chemotherapy

J Zhao, Y Peng, D Diaz-Dussan, J White, W Duan, L Kong, R Narain, X Hao

(2022), Vol. 19, pp. 1766-1777, Molecular Pharmaceutics, United States, C1

Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study

Q Zhang, H Huang, A Sun, C Liu, Z Wang, F Shi, W Duan, X Sun, Q Wang, P Sun, C Pu, Y Zhang

(2022), Vol. 10, pp. 390-397, Journal of Clinical and Translational Hepatology, China, C1

A novel navigated doxorubicin delivery formulation to breast cancer therapy

S Cheng, Z Lu, Y Feng, X Zhao, R Zhao, Z Qiu, C Jia, L Chen, Y Yuan, X Li, Q Gao, J Xu, Z Shu, W Duan, Y Hou, G Nie, L Xiao

(2022), Vol. 14, pp. 1-14, Materials Today Advances, Amsterdam, The Netherlands, C1

Temperature-Responsive Aldehyde Hydrogels with Injectable, Self-Healing, and Tunable Mechanical Properties

J Zhao, Y Peng, J Wang, D Diaz-Dussan, W Tian, W Duan, L Kong, X Hao, R Narain

(2022), Vol. 23, pp. 2552-2561, Biomacromolecules, Washington, D.C., C1

Selection and identification of a specific peptide binding to ovarian cancer cells from a phage-displayed peptide library

Q Gao, L Chen, C Jia, Y Yuan, X Li, Z Lu, Y Feng, R Zhao, X Zhao, Y Wang, S Cheng, C Zhang, J Xu, Z Shu, W Duan, G Nie, L Xiao, Y Hou

(2022), Vol. 44, pp. 951-960, Biotechnology Letters, Netherlands, C1

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin

W Yin, C Pham, T Wang, H Al Shamaileh, R Chowdhury, S Patel, Y Li, L Kong, Y Hou, Y Zhu, S Chen, H Xu, L Jia, W Duan, D Xiang

(2022), Vol. 12, pp. 1-14, Biomolecules, Basel, Switzerland, C1

Neuroprotective Effect of Phthalide Derivative CD21 against Ischemic Brain Injury:Involvement of MSR1 Mediated DAMP peroxiredoxin1 Clearance and TLR4 Signaling Inhibition

X Zou, X Yang, Y Gan, D Liu, C Chen, W Duan, J Du

(2021), Vol. 16, pp. 306-317, Journal of Neuroimmune Pharmacology, United States, C1

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

H Jin, X Gao, L Xiao, H He, S Cheng, C Zhang, Y Hou, F Song, X Su, Q Gao, Z Lu, R Yang, X Song, J Yang, W Duan, Y Hou

(2021), Vol. 43, pp. 153-164, Biotechnology Letters, Netherlands, C1

Dual-Cross-Linked Network Hydrogels with Multiresponsive, Self-Healing, and Shear Strengthening Properties

J Zhao, D Diaz-Dussan, M Wu, Y Peng, J Wang, H Zeng, W Duan, L Kong, X Hao, R Narain

(2021), Vol. 22, pp. 800-810, Biomacromolecules, United States, C1

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

G Zhou, S Da Won Bae, R Nguyen, X Huo, S Han, Z Zhang, L Hebbard, W Duan, M Eslam, C Liddle, L Yuen, V Lam, L Qiao, J George

(2021), Vol. 501, pp. 124-132, Cancer Letters, Ireland, C1

Age-related cognitive decline is associated with microbiota-gut-brain axis disorders and neuroinflammation in mice

M Wu, X Yang, L Xue, W Duan, J Du

(2021), Vol. 402, Behavioural Brain Research, Netherlands, C1

The APEX1/miRNA-27a-5p axis plays key roles in progression, metastasis and targeted chemotherapy of gastric cancer

H He, F Song, Q Gao, Z Lu, Y Yuan, X Li, L Chen, C Jia, R Yang, J Yang, W Duan, Y Hou

(2021), Vol. 599, International Journal of Pharmaceutics, Netherlands, C1

Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis

X Meng, J Wang, J Zhou, Q Tian, B Qie, G Zhou, W Duan, Y Zhu

(2021), Vol. 127, pp. 266-275, Acta biomaterialia, Amsterdam, The Netherlands, C1

Cancer Stem Cell-Targeted Gene Delivery Mediated by Aptamer-Decorated pH-Sensitive Nanoliposomes

P Moitra, S Misra, K Kumar, P Kondaiah, P Tran, W Duan, S Bhattacharya

(2021), Vol. 7, pp. 2508-2519, ACS Biomaterials Science and Engineering, Washington, Eng., C1

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells

W Yin, D Xiang, T Wang, Y Zhang, C Pham, S Zhou, G Jiang, Y Hou, Y Zhu, Y Han, L Qiao, P Tran, W Duan

(2021), Vol. 11, Scientific Reports, England, C1

Bovine extracellular vesicles contaminate human extracellular vesicles produced in cell culture conditioned medium when 'exosome-depleted serum' is utilised

C Pham, S Midge, H Barua, Y Zhang, T Ngoc-Gia Nguyen, R Barrero, A Duan, W Yin, G Jiang, Y Hou, S Zhou, Y Wang, X Xie, P Tran, D Xiang, W Duan

(2021), Vol. 708, Archives of Biochemistry and Biophysics, United States, C1

ITGB1 Enhances the Proliferation, Survival, and Motility in Gastric Cancer Cells

S Cheng, X Li, Y Yuan, C Jia, L Chen, Q Gao, Z Lu, R Yang, G Nie, J Yang, W Duan, L Xiao, Y Hou

(2021), Vol. 27, pp. 1192-1201, Microscopy and Microanalysis, C1

Lef1 enhances the progression of colonic adenocarcinoma via remodeling the cell motility associated structures

L Xiao, C Zhang, X Li, C Jia, L Chen, Y Yuan, Q Gao, Z Lu, Y Feng, R Zhao, X Zhao, S Cheng, Z Shu, J Xu, W Duan, G Nie, Y Hou

(2021), Vol. 22, International Journal of Molecular Sciences, Switzerland, C1

Bioinformatic identification of key biomarkers in the brain and blood involved in ischemia preconditioning protection against acute ischemic stroke in mice

Yu-Xin Yang, Mei-Ling Wu, Ou Du, Wei Duan, Jun-Rong Du

(2021), Vol. 14, pp. 1628-+, International Journal of Clinical and Experimental Medicine, Madison, Wis., C1

Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model

K Zhou, X Huo, R Nguyen, S Bae, S Han, Z Zhang, W Duan, L Yuen, V Lam, J George, L Qiao

(2021), Vol. 341, pp. 341-350, Journal of Controlled Release, Amsterdam, The Netherlands, C1

Exosomes and nanoengineering: a match made for precision therapeutics

Phuong Tran, Dongxi Xiang, Thao Tran, Wang Yin, Yumei Zhang, Lingxue Kong, Kuisheng Chen, Miaomiao Sun, Yong Li, Yingchun Hou, Yimin Zhu, Wei Duan

(2020), Vol. 32, pp. 1-8, Advanced materials, Weinheim, Germany, C1

Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel

P Ha-Lien Tran, T Wang, C Yang, T Tran, W Duan

(2020), Vol. 107, Materials Science and Engineering C, Netherlands, C1

Fucoidan-based nanostructures: A focus on its combination with chitosan and the surface functionalization of metallic nanoparticles for drug delivery

P Tran, W Duan, T Tran

(2020), Vol. 575, International Journal of Pharmaceutics, Netherlands, C1

Current perspectives on delivery systems using extracellular vesicles in neurological disease

P Tran, W Duan, B Lee, T Tran

(2020), Vol. 26, pp. 764-771, Current pharmaceutical design, Sharjah, United Arab Emirates, C1

CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo

J Ni, B Cheung, J Beretov, W Duan, J Bucci, D Malouf, P Graham, Y Li

(2020), Vol. 388, Experimental Cell Research, United States, C1

Aptamer-guided extracellular vesicle theranostics in oncology

P Tran, D Xiang, T Nguyen, T Tran, Q Chen, W Yin, Y Zhang, L Kong, A Duan, K Chen, M Sun, Y Li, Y Hou, Y Zhu, Y Ma, G Jiang, W Duan

(2020), Vol. 10, pp. 3849-3866, Theranostics, Australia, C1

CDKL3 promotes osteosarcoma progression by activating Akt/PKB

A He, L Ma, Y Huang, H Zhang, W Duan, Z Li, T Fei, J Yuan, H Wu, L Liu, Y Bai, W Dai, Y Wang, H Li, Y Sun, Y Wang, C Wang, T Yuan, Q Yang, S Tian, M Dong, R Sheng, D Xiang

(2020), Vol. 3, Life Science Alliance, United States, C1

In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers

D Bell, J Weber, W Yin, T Huynh, W Duan, R Zhou

(2020), Vol. 117, pp. 8486-8493, Proceedings of the National Academy of Sciences of the United States of America, Washington, D.C., C1

Roles of N-terminal Annexin A2 phosphorylation sites and miR-206 in colonic adenocarcinoma

L Xiao, H Jin, W Duan, Y Hou

(2020), Vol. 253, Life Sciences, Netherlands, C1

Emerging technologies for profiling extracellular vesicle heterogeneity

G Huang, G Lin, Y Zhu, W Duan, D Jin

(2020), Vol. 20, pp. 2423-2437, Lab on a Chip, London, Eng., C1

Ring opening polymerization of α-amino acids: Advances in synthesis, architecture and applications of polypeptides and their hybrids

A Rasines Mazo, S Allison-Logan, F Karimi, N Chan, W Qiu, W Duan, N O'Brien-Simpson, G Qiao

(2020), Vol. 49, pp. 4737-4834, Chemical Society Reviews, England, C1

Phthalide derivative CD21 alleviates cerebral ischemia-induced neuroinflammation: Involvement of microglial M2 polarization via AMPK activation

Y Gan, D Liu, C Chen, W Duan, Y Yang, J Du

(2020), Vol. 886, European Journal of Pharmacology, Netherlands, C1

Exosomes and breast cancer drug resistance

X Dong, X Bai, J Ni, H Zhang, W Duan, P Graham, Y Li

(2020), Vol. 11, Cell Death and Disease, England, C1

Facile Preparation of Macromolecular Prodrugs for Hypoxia-Specific Chemotherapy

J Zhao, D Diaz-Dussan, Z Jiang, Y Peng, J White, W Duan, R Narain, X Hao, L Kong

(2020), Vol. 9, pp. 1687-1692, ACS Macro Letters, United States, C1

Development of a novel drug targeting delivery system for cervical cancer therapy

Y Hou, L Xiao, N Ma, H He, J Li, S Cheng, Q Yang, Y Hou, F Song, H Jin, X Su, J Dong, R Zuo, X Song, W Duan

(2019), Vol. 30, Nanotechnology, England, C1

A Detailed Protein-SELEX Protocol Allowing Visual Assessments of Individual Steps for a High Success Rate

T Wang, W Yin, H AlShamaileh, Y Zhang, P Tran, T Nguyen, Y Li, K Chen, M Sun, Y Hou, W Zhang, Q Zhao, C Chen, P Zhang, W Duan

(2019), Vol. 30, pp. 1-16, Human Gene Therapy Methods, United States, C1

Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer's disease-like pathology and cognitive deficits in mice

C Zeng, T Yang, H Zhou, Y Zhao, X Kuang, W Duan, J Du

(2019), Vol. 78, pp. 18-28, Neurobiology of Aging, United States, C1

Annexin A2 enhances the progression of colorectal cancer and hepatocarcinoma via cytoskeleton structural rearrangements

H He, L Xiao, S Cheng, Q Yang, J Li, Y Hou, F Song, X Su, H Jin, Z Liu, J Dong, R Zuo, X Song, Y Wang, K Zhang, W Duan, Y Hou

(2019), Vol. 25, pp. 950-960, Microscopy and Microanalysis, United States, C1

The use of zein in the controlled release of poorly water-soluble drugs

P Tran, W Duan, B Lee, T Tran

(2019), Vol. 566, pp. 557-564, International Journal of Pharmaceutics, Netherlands, C1

Development of a nanoamorphous exosomal delivery system as an effective biological platform for improved encapsulation of hydrophobic drugs

P Tran, T Wang, W Yin, T Tran, H Barua, Y Zhang, S Midge, T Nguyen, B Lee, W Duan

(2019), Vol. 566, pp. 697-707, International Journal of Pharmaceutics, Netherlands, C1

Nanogels for skin cancer therapy via transdermal delivery: current designs

P Tran, W Duan, B Lee, T Tran

(2019), Vol. 20, pp. 575-582, Current drug metabolism, Beijing, China, C1

Modulation of drug crystallization and molecular interactions by additives in solid dispersions for improving drug bioavailability

P Tran, W Duan, B Lee, T Tran

(2019), Vol. 25, pp. 2099-2107, Current Pharmaceutical Design, United Arab Emirates, C1

Drug stabilization in the gastrointestinal tract and potential applications in the colonic delivery of oral zein-based formulations

P Tran, W Duan, B Lee, T Tran

(2019), Vol. 569, International Journal of Pharmaceutics, Netherlands, C1

Recent developments of nanoparticle-delivered dosage forms for buccal delivery

P Tran, W Duan, T Tran

(2019), Vol. 571, International Journal of Pharmaceutics, Netherlands, C1

Aspirin-loaded nanoexosomes as cancer therapeutics

P Tran, T Wang, W Yin, T Tran, T Nguyen, B Lee, W Duan

(2019), Vol. 572, International Journal of Pharmaceutics, Netherlands, C1

Tailored mesoporous silica nanoparticles for controlled drug delivery: Platform fabrication, targeted delivery, and computational design and analysis

X She, L Chen, Z Yi, C Li, C He, C Feng, T Wang, S Shigdar, W Duan, L Kong

(2018), Vol. 18, pp. 976-989, Mini-Reviews in Medicinal Chemistry, Netherlands, C1

Encapsulation of solid dispersion in solid lipid particles for dissolution enhancement of poorly water-soluble drug

K Tran, T Van Vo, B Lee, W Duan, P Tran, T Tran

(2018), Vol. 15, pp. 576-584, Current Drug Delivery, United Arab Emirates, C1

Aptamers as potential therapeutic agents for ovarian cancer

J Henri, J Macdonald, M Strom, W Duan, S Shigdar

(2018), Vol. 145, pp. 34-44, Biochimie, Amsterdam, The Netherlands, C1

Mesoporous silica nanorods toward efficient loading and intracellular delivery of siRNA

L Chen, X She, T Wang, S Shigdar, W Duan, L Kong

(2018), Vol. 20, Journal of Nanoparticle Research, C1

Switching off the interactions between graphene oxide and doxorubicin using Vitamin C: Combining simplicity and efficiency in drug delivery

Z Liu, J Liu, T Wang, Q Li, P Francis, C Barrow, W Duan, W Yang

(2018), Vol. 6, pp. 1251-1259, Journal of Materials Chemistry B, England, C1

Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers

G Zhou, O Latchoumanin, L Hebbard, W Duan, C Liddle, J George, L Qiao

(2018), Vol. 134, pp. 107-121, Advanced drug delivery reviews, Amsterdam, The Netherlands, C1

Current designs of polymer blends in solid dispersions for improving drug bioavailability

P Tran, W Duan, B Lee, T Tran

(2018), Vol. 19, pp. 1111-1118, Current Drug Metabolism, Netherlands, C1

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo

J Ni, P Cozzi, J Beretov, W Duan, J Bucci, P Graham, Y Li

(2018), Vol. 18, BMC Cancer, England, C1

Challenges and opportunities for siRNA-based cancer treatment

T Wang, S Shigdar, H Shamaileh, M Gantier, W Yin, D Xiang, L Wang, S Zhou, Y Hou, P Wang, W Zhang, C Pu, W Duan

(2017), Vol. 387, pp. 77-83, Cancer Letters, Ireland, C1

Sonication-assisted nanoprecipitation in drug delivery

A Vo, T Luu, M Nguyen, T Vo, W Duan, P Tran, T Tran

(2017), Vol. 18, pp. 145-156, Current Drug Metabolism, Netherlands, C1

Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer Metastases

J Macdonald, J Henri, L Goodman, D Xiang, W Duan, S Shigdar

(2017), Vol. 8, pp. 777-784, ACS Chemical Neuroscience, United States, C1

Strategies of engineering nanoparticles for treating neurodegenerative disorders

K Nguyen, M Pham, T Van Vo, W Duan, P Tran, T Truong-Dinh Tran

(2017), Vol. 18, pp. 786-797, Current Drug Metabolism, Netherlands, C1

Predictive value of UGT1A1*28 polymorphism in irinotecan-based chemotherapy

X-H Liu, J Lu, W Duan, Z-M Dai, M Wang, S Lin, P-T Yang, T Tian, K Liu, Y-Y Zhu, Y Zheng, Q-W Sheng, Z-J Dai

(2017), Vol. 8, pp. 691-703, Journal of cancer, Wyoming, N.S.W., C1

Nanotechnology in neuroscience and its perspective as gene carrier

T Khanh, D Wei, P Tran, T Tran

(2017), Vol. 17, pp. 1379-1389, Current Topics in Medicinal Chemistry, United Arab Emirates, C1-1

Effects of miR-29a and miR-101a expression on myocardial interstitial collagen generation after aerobic exercise in myocardial-infarcted rats

L Xiao, H He, L Ma, M Da, S Cheng, Y Duan, Q Wang, H Wu, X Song, W Duan, Z Tian, Y Hou

(2017), Vol. 48, pp. 27-34, Archives of medical research, Amsterdam, The Netherlands, C1

New pH-responsive gemini lipid derived co-liposomes for efficacious doxorubicin delivery to drug resistant cancer cells

P Moitra, K Kumar, S Sarkar, P Kondaiah, W Duan, S Bhattacharya

(2017), Vol. 53, pp. 8184-8187, Chemical Communications, England, C1

Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells

H Alshamaileh, T Wang, D Xiang, W Yin, P Tran, R Barrero, P Zhang, Y Li, L Kong, K Liu, S Zhou, Y Hou, S Shigdar, W Duan

(2017), Vol. 7, Scientific Reports, England, C1

Nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates for dissolution enhancement of poorly water-soluble drugs

H Dinh, P Tran, W Duan, B Lee, T Tran

(2017), Vol. 533, pp. 93-98, International Journal of Pharmaceutics, Netherlands, C1

Aptamer-based therapeutic approaches to target cancer stem cells

G Zhou, O Latchoumanin, M Bagdesar, L Hebbard, W Duan, C Liddle, J George, L Qiao

(2017), Vol. 7, pp. 3948-3961, Theranostics, Australia, C1

Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery

D Xiang, S Shigdar, A Bean, M Bruce, W Yang, M Mathesh, T Wang, W Yin, P Tran, H Shamaileh, R Barrero, P Zhang, Y Li, L Kong, K Liu, S Zhou, Y Hou, A He, W Duan

(2017), Vol. 7, pp. 4071-4086, Theranostics, Australia, C1

Nanoprecipitation for poorly water-soluble drugs

T Nguyen, V Tran, W Duan, P Tran, T Tran

(2017), Vol. 18, pp. 1000-1015, Current Drug Metabolism, Netherlands, C1

Conjugation strategies for colonic delivery and its application in colorectal cancer therapy

P Tran, W Duan, T Tran

(2017), Vol. 18, pp. 1016-1019, Current drug metabolism, Beijing, China, C1

Aptamers and glioblastoma: Their potential use for imaging and therapeutic applications

E Hays, W Duan, S Shigdar

(2017), Vol. 18, International Journal of Molecular Sciences, Switzerland, C1

Development of a Sustained Release Solid Dispersion Using Swellable Polymer by Melting Method

T Nguyen, P Tran, T Van Vo, W Duan, T Truong-Dinh Tran

(2016), Vol. 33, pp. 102-109, Pharmaceutical Research, United States, C1

Development of drug-loaded chitosan-vanillin nanoparticles and its cytotoxicity against HT-29 cells

P-W Li, G Wang, Z-M Yang, W Duan, Z Peng, L-X Kong, Q-H Wang

(2016), Vol. 23, pp. 30-35, Drug delivery, Abingdon, Eng., C1

The Application of Aptamers for Immunohistochemistry

M Bauer, J Macdonald, J Henri, W Duan, S Shigdar

(2016), Vol. 26, pp. 120-126, Nucleic Acid Therapeutics, United States, C1

Aptamers: a promising chemical antibody for cancer therapy

G Zhou, G Wilson, L Hebbard, W Duan, C Liddle, J George, L Qiao

(2016), Vol. 7, pp. 13446-13463, Oncotarget, Albany, N.Y., C1

ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures

H Shi, L Xiao, W Duan, H He, L Ma, M Da, Y Duan, Q Wang, H Wu, X Song, Y Hou

(2016), Vol. 85, pp. 26-33, Micron, England, C1

Perspectives of engineered marine derived polymers for biomedical nanoparticles

K Tran, T Vo, W Duan, P Tran, T Tran

(2016), Vol. 22, pp. 2844-2856, Current Pharmaceutical Design, United Arab Emirates, C1

An investigation of effects of modification processes on physical properties and mechanism of drug release for sustaining drug release from modified rice

V Ngo, T Luu, T Van Vo, V Tran, W Duan, P Tran, T Tran

(2016), Vol. 67, pp. 1-7, Materials Science and Engineering C, Netherlands, C1

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer

J Deng, L Wang, H Chen, J Hao, J Ni, L Chang, W Duan, P Graham, Y Li

(2016), Vol. 7, pp. 55771-55788, Oncotarget, Orchard Park, N.Y., C1

Investigation of fucoidan-oleic acid conjugate for delivery of curcumin and paclitaxel

U Phan, K Nguyen, T Vo, W Duan, P Tran, T Tran

(2016), Vol. 16, pp. 1281-1287, Anti-Cancer Agents in Medicinal Chemistry, Netherlands, C1

Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding Affinity

J MacDonald, P Houghton, D Xiang, W Duan, S Shigdar

(2016), Vol. 26, pp. 348-354, Nucleic Acid Therapeutics, United States, C1

Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells

S He, L Shu, Z Zhou, T Yang, W Duan, X Zhang, Z He, S Zhou

(2016), Vol. 382, pp. 215-230, Cancer Letters, Ireland, C1

Hydrophilic-hydrophobic polymer blend for modulation of crystalline changes and molecular interactions in solid dispersion

H Van Ngo, P Nguyen, T Van Vo, W Duan, V Tran, P Tran, T Tran

(2016), Vol. 513, pp. 148-152, International Journal of Pharmaceutics, Netherlands, C1

Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy

J Deng, L Wang, J Ni, J Beretov, V Wasinger, D Wu, W Duan, P Graham, Y Li

(2016), Vol. 13, pp. 905-915, Expert Review of Proteomics, England, C1

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy

J Hao, P Graham, L Chang, J Ni, V Wasinger, J Beretov, J Deng, W Duan, J Bucci, D Malouf, D Gillatt, Y Li

(2016), Vol. 7, pp. 74269-74285, Oncotarget, United States, C1

indium doped and carbon modified p25 nanocomposites with high visible-light sensitivity for the photocatalytic degradation of organic dyes

Z Jin, W Duan, W Duan, B Liu, X Chen, F Yang, J Guo

(2016), Vol. 517, pp. 129-140, Applied Catalysis A: General, Amsterdam, The Netherlands, C1-1

A protocol for improving fabrication yield of thin SU-8 microcantilevers for use in an aptasensor

Y Lim, A Kouzani, A Kaynak, X Dai, G Littlefair, W Duan

(2015), Vol. 21, pp. 371-380, Microsystem technologies, Berlin, Germany, C1

Epigallocatechin-3-gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not non-cancerous liver cells.

Y Zhang, W Duan, L Owusu, D Wu, Y Xin

(2015), Vol. 35, pp. 117-124, International Journal of Molecular Medicine, Athens, Greece, C1

Graphene quantum dots induce apoptosis, autophagy, and inflammatory response via p38 mitogen-activated protein kinase and nuclear factor-κB mediated signaling pathways in activated THP-1 macrophages.

Y Qin, Z Zhou, S Pan, Z He, X Zhang, J Qiu, W Duan, T Yang, S Zhou

(2015), Vol. 327, pp. 62-76, Toxicology, Ireland, C1

Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine

D Xiang, S Shigdar, G Qiao, T Wang, A Kouzani, S Zhou, L Kong, Y Li, C Pu, W Duan

(2015), Vol. 5, pp. 23-42, Theranostics, Wyoming, N.S.W., C1

Aptamer-mediated cancer gene therapy.

D Xiang, S Shigdar, G Qiao, S Zhou, Y Li, M Wei, L Qiao, H Shamaileh, Y Zhu, C Zheng, C Pu, W Duan

(2015), Vol. 15, pp. 109-119, Current Gene Therapy, Bussum, Netherlands, C1

Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.

X She, L Chen, L Velleman, C Li, H Zhu, C He, T Wang, S Shigdar, W Duan, L Kong

(2015), Vol. 445, pp. 151-160, Journal of Colloid and Interface Science, United States, C1

Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.

Y Ding, Z Zhou, C Ha, X Zhang, S Pan, Z He, J Edelman, D Wang, Y Yang, X Zhang, W Duan, T Yang, J Qiu, S Zhou

(2015), Vol. 9, pp. 425-464, Drug Design, Development and Therapy, New Zealand, C1

The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells

J Li, Y Yang, Q Liu, Z Zhou, S Pan, Z He, X Zhang, T Yang, S Pan, W Duan, S He, X Chen, J Qiu, S Zhou

(2015), Vol. 9, pp. 1027-1062, Drug design, development and therapy, Macclesfield, Eng., C1

Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells

Y Wang, Y Yang, R Zhao, S Pan, H Zhe, Z He, W Duan, X Zhang, T Yang, J Qiu, S Zhou

(2015), Vol. 9, pp. 993-1026, Drug design, development and therapy, Auckland, New Zealand, C1

Clinical association between pharmacogenomics and adverse drug reactions

Z Zhou, X Chen, K Sneed, Y Yang, X Zhang, Z He, K Chow, T Yang, W Duan, S Zhou

(2015), Vol. 75, pp. 589-631, Drugs, Basel, Switzerland, C1

Sch9 regulates intracellular protein ubiquitination by controlling stress responses

B Qie, Z Lyu, L Lyu, J Liu, X Gao, Y Liu, W Duan, N Zhang, L Du, K Liu

(2015), Vol. 5, pp. 290-300, Redox biology, Amsterdam, The Netherlands, C1

Chansu inhibits the expression of cortactin in colon cancer cell lines in vitro and in vivo

C Li, S Hashimi, S Cao, J Qi, D Good, W Duan, M Wei

(2015), Vol. 15, pp. 1-8, BMC complementary and alternative medicine, London, Eng., C1

Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus

X Chen, Z He, Z Zhou, T Yang, X Zhang, Y Yang, W Duan, S Zhou

(2015), Vol. 42, pp. 999-1024, Clinical and experimental pharmacology and physiology, London, Eng., C1

Cisplatin-induced formation of biocompatible and biodegradable polypeptide-based vesicles for targeted anticancer drug delivery

S Shirbin, K Ladewig, Q Fu, M Klimak, X Zhang, W Duan, G Qiao

(2015), Vol. 16, pp. 2463-2474, Biomacromolecules, Washington, D.C., C1

The control of epidermal growth factor grafted on mesoporous silica nanoparticles for targeted delivery

X She, L Chen, L Velleman, C Li, C He, J Denman, T Wang, S Shigdar, W Duan, L Kong

(2015), Vol. 3, pp. 6094-6104, Journal of materials chemistry B, Cambridge, Eng., C1

Superior performance of aptamer in tumor penetration over antibody : implication of aptamer-based theranostics in solid tumors

D Xiang, C Zheng, S Zhou, S Qiao, P Tran, C Pu, Y Li, L Kong, A Kouzani, J Lin, K Liu, L Li, S Shigdar, W Duan

(2015), Vol. 5, pp. 1083-1097, Theranostics, Sydney, N.S.W., C1

An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus.

X Chen, Z He, Z Zhou, T Yang, X Zhang, Y Yang, W Duan, S Zhou

(2015), Vol. 42, pp. 1225-1238, Clinical and experimental pharmacology and physiology, London, Eng., C1

Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles

L Chen, X She, T Wang, L He, S Shigdar, W Duan, L Kong

(2015), Vol. 7, pp. 14080-14092, Nanoscale, Cambridge, Eng., C1

Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex

J Yin, S Shumyak, C Burgess, Z Zhou, Z He, X Zhang, S Pan, T Yang, W Duan, J Qiu, S Zhou

(2015), Vol. 10, pp. 4717-4730, International journal of nanomedicine, Auckland, N. Z., C1

Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study

N Niu, J Yin, Y Yang, Z Wang, Z Zhou, Z He, X Chen, X Zhang, W Duan, T Yang, S Zhou

(2015), Vol. 9, pp. 4441-4470, Drug design, development and therapy, Macclesfield, Eng., C1

Cancer stem cell targeted therapy: progress amid controversies

T Wang, S Shigdar, M Gantier,, Y Hou,, L Wang,, Y Li,, H Shamaileh,, W Yin, S Zhou,, X Zhao,, W Duan

(2015), Vol. 6, pp. 44191-44206, Oncotarget, Albany, N.Y., C1

EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model

T Wang, M Gantier, D Xiang, A Bean, M Bruce, S Zhou, M Khasraw, A Ward, L Wang, M Wei, H AlShamaileh, L Chen, X She, J Lin, L Kong, S Shigdar, W Duan

(2015), Vol. 5, pp. 1456-1472, Theranostics, Wyoming, N.S.W., C1

A surface-stress-based microcantilever aptasensor

Y Lim, A Kouzani, W Duan, X Dai, A Kaynak, D Mair

(2014), Vol. 8, pp. 15-24, IEEE transactions on biomedical circuits and systems, Piscataway, NJ, C1

Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model

J Lin, S Shigdar, D Fang, D Xiang, M Wei, A Danks, L Kong, L Li, L Qiao, W Duan

(2014), Vol. 9, pp. 1-13, Plos One, San Francisco, CA, C1

Multifunctional nanoparticle-EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy

M Das, W Duan, S Sahoo

(2014), pp. 1-11, Nanomedicine : nanotechnology, biology and medicine, Amsterdam, The Netherlands, C1

Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells.

A Tian, G Wilson, S Lie, G Wu, Z Hu, L Hebbard, W Duan, J George, L Qiao

(2014), Vol. 351, pp. 232-241, Cancer Letters, Ireland, C1

Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells

Y Li, S He, Z He, M Li, Y Yang, J Pang, X Zhang, K Chow, Q Zhou, W Duan, Z Zhou, T Yang, G Huang, A Liu, J Qiu, J Liu, S Zhou

(2014), Vol. 344, pp. 239-259, Cancer Letters, Shannon, County Clare, Ireland, C1

Cancer stem cells: a contentious hypothesis now moving forward

M O'Connor, D Xiang, S Shigdar, J Macdonald, Y Li, T Wang, C Pu, Z Wang, L Qiao, W Duan

(2014), Vol. 344, pp. 180-187, Cancer letters, Shannon, Ireland, C1

Cancer stem cells in prostate cancer chemoresistance

J Ni, P Cozzi, J Hao, W Duan, P Graham, J Kearsley, Y Li

(2014), Vol. 14, pp. 225-240, Current cancer drug targets, Bussum, Netherlands, C1

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance

J Ni, P Cozzi, J Hao, J Beretov, L Chang, W Duan, S Shigdar, W Delprado, P Graham, J Bucci, J Kearsley, Y Li

(2014), Vol. 74, pp. 602-617, Prostate, Hoboken, NJ, C1

Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies

Z-X Wang, J Sun, C Howell, Q-Y Zhou, Z-X He, T Yang, H Chew, W Duan, Z-W Zhou, J Kanwar, S-F Zhou

(2014), Vol. 28, pp. 551-582, Fundamental and clinical pharmacology, Chichester, England, C1

Smoothened activates breast cancer stem-like cell and promotes tumorigenesis and metastasis of breast cancer

L Wang, W Duan, L Kang, J Mao, X Yu, S Fan, L Li, Y Tao

(2014), Vol. 68, pp. 1099-1104, Biomedicine & pharmacotherapy, Amsterdam, The Netherlands, C1

Theoretical modeling and experimental validation of surface stress in thrombin aptasensor

Y Lim, A Kouzani, A Kaynak, X Dai, G Littlefair, W Duan

(2014), Vol. 13, pp. 384-391, IEEE Transactions on Nanobioscience, United States, C1

Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells

L Li, D Xiang, S Shigdar, W Yang, Q Li, J Lin, K Liu, W Duan

(2014), Vol. 9, pp. 1083-1096, International journal of nanomedicine, Macclesfield, England, C1

Exposure to 1800 MHz radiofrequency radiation impairs neurite outgrowth of embryonic neural stem cells

C Chen, Q Ma, C Liu, P Deng, G Zhu, L Zhang, M He, Y Lu, W Duan, L Pei, M Li, Z Yu, Z Zhou

(2014), Vol. 4, pp. 1-10, Scientific reports, London, Eng., C1-1

∝-mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion

J Lei, X Huo, W Duan, Q Xu, R Li, J Ma, X Li, L Han, W Li, H Sun, E Wu, Q Ma

(2014), Vol. 347, pp. 129-138, Cancer letters, Amsterdam, The Netherlands, C1-1

Localized surface plasmon resonance: nano-sinusoid arrays

D Mortazavi, A Kouzani, L Matekovits, W Duan

(2013), Vol. 27, pp. 638-648, Journal of electromagnetic waves and applications, London, Eng., C1

Cloning of the crustacean hyperglycemic hormone and evidence for molt-inhibiting hormone within the central nervous system of the blue crab Portunus pelagicus

M Stewart, P Stewart, M Sroyraya, N Soonklang, S Cummins, P Hanna, W Duan, P Sobhon

(2013), Vol. 164, pp. 276-290, Comparative biochemistry and physiology. Part A : molecular & integrative physiology, New York, N.Y., C1

RNA aptamers targeting cancer stem cell marker CD133

S Shigdar, L Qiao, S Zhou, D Xiang, T Wang, Y Li, L Lim, L Kong, L Li, W Duan

(2013), Vol. 330, pp. 84-95, Cancer letters, Amsterdam, Netherlands, C1

The use of sensitive chemical antibodies for diagnosis: detection of low levels of Epcam in breast cancer

S Shigdar, C Qian, L Lv, C Pu, Y Li, L Li, M Marappan, J Lin, L Wang, W Duan

(2013), Vol. 8, pp. 1-8, PLoS One, San Diego, United States, C1

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway

J Ni, P Cozzi, J Hao, J Beretov, L Chang, W Duan, S Shigdar, W Delprado, P Graham, J Bucci, J Kearsley, Y Li

(2013), Vol. 45, pp. 2736-2748, International journal of biochemistry and cell biology, Amsterdam, The Netherlands, C1

Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo

D Xiang, Z Yang, W Duan, X Li, J Yin, S Shigdar, M O'Connor, M Marappan, X Zhao, Y Miao, B Xiang, C Zheng

(2013), Vol. 8, pp. 4103-4114, International Journal of Nanomedicine, Macclesfield, UK, C1

Inflammation and cancer stem cells

S Shigdar, Y Li, S Bhattacharya, M O'Connor, C Pu, J Lin, T Wang, D Xiang, L Kong, M Wei, Y Zhu, S Zhou, W Duan

(2013), Vol. 345, pp. 271-278, Cancer letters, Amsterdam, The Netherlands, C1

Aptamers as theranostic agents: modifications, serum stability and functionalisation

S Shigdar, J Macdonald, M O'Connor, T Wang, D Xiang, H Al.Shamaileh, L Qiao, M Wei, S Zhou, Y Zhu, L Kong, S Bhattacharya, C Li, W Duan

(2013), Vol. 13, pp. 13624-13637, Sensors, Basel, Switzerland, C1

Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture

Y Song, Z Zhu, Y An, W Zhang, H Zhang, D Liu, C Yu, W Duan, C Yang

(2013), Vol. 85, pp. 4141-4149, Analytical chemistry, Washington DC, C1

Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment

J Yin, S Sharma, S Shumyak, Z Wang, Z Zhou, Y Zhang, P Guo, C Li, J Kanwar, T Yang, S Mohapatra, W Liu, W Duan, J Wang, Q Li, X Zhang, J Tan, L Jia, J Liang, M Wei, X Li, S Zhou

(2013), Vol. 8, pp. 1-20, PLOS one, San Francisco, California, C1

Peptide-fluorescent bacteria complex as luminescent reagents for cancer diagnosis

B Dong, A Wang, L Yuan, L Chen, K Pu, W Duan, X Yan, Y Zhu

(2013), Vol. 8, PLOS One, San Francisco, California, C1

Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells

G Wilson, Z Hu, W Duan, A Tian, X Wang, D McLeod, V Lam, J George, L Qiao

(2013), Vol. 22, pp. 2655-2664, Stem Cells and Development, New Rochelle, NY, C1

Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells

Y Zhang, L Owusu, W Duan, T Jiang, S Zang, A Ahmed, Y Xin

(2013), Vol. 32, pp. 959-964, International journal of molecular medicine, Athens, Greece, C1

Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro

G Wilson, A Tian, L Hebbard, W Duan, J George, X Li, L Qiao

(2013), Vol. 341, pp. 224-230, Cancer letters, Amsterdam, The Netherlands, C1

Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers

S Dawar, N Singh, R Kanwar, R Kennedy, R Veedu, S Zhou, S Krishnakumar, S Hazra, S Sasidharan, W Duan, J Kanwar

(2013), Vol. 18, pp. 1292-1300, Drug discovery today, London, England, C1

The mechanisms of Chansu in inducing efficient apoptosis in colon cancer cells

C Li, S Hashimi, S Cao, A Mellick, W Duan, D Good, M Wei

(2013), Vol. 2013, pp. 1-11, Evidence-based complementary and alternative medicine, New York, N. Y., C1

Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells

A Wang, K Pu, B Dong, Y Liu, L Zhang, Z Zhang, Duan Wei, Y Zhu

(2013), Vol. 33, pp. 1156-1164, Journal of applied toxicology, Bognor Regis, England, C1-1

Developing lspr design guidelines

D Mortazavi, A Kouzani, A Kaynak, W Duan

(2012), Vol. 126, pp. 203-235, Progress in electromagnetics research, Cambridge, Mass., C1

Cancer stem cell targeting : the next generation of cancer therapy and molecular imaging

S Shigdar, J Lin, Y Li, C Yang, M Wei, Y Zhu, H Liu, W Duan

(2012), Vol. 3, pp. 227-244, Therapeutic delivery, London, England, C1

Clostridial spores for cancer therapy : targeting solid tumour microenvironment

B Umer, D Good, J Anne, W Duan, M Wei

(2012), Vol. 2012, pp. 1-8, Journal of toxicology, New York, N.Y., C1

Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer

J Lin, Y Yu, S Shigdar, D Fang, J Rong Du, M Wei, A Danks, K Liu, W Duan

(2012), Vol. 7, pp. 1-10, Plos One, San Francisco, Calif., C1-1

Apoptosis and microRNA aberrations in cancer

C Li, S Hashimi, D Good, S Cao, W Duan, P Plummer, A Mellick, M Wei

(2012), Vol. 39, pp. 739-746, Clinical and experimental pharmacology and physiology, Australia, C1

Role of the EpCAM (CD326) in prostate cancer metastasis and progression

J Ni, P Cozzi, W Duan, S Shigdar, P Graham, K John, Y Li

(2012), Vol. 31, pp. 779-791, Cancer metastasis reviews, New York, N. Y., C1

Elevated levels of triglyceride and triglyceride-rich lipoprotein triglyceride induced by a high-carbohydrate diet is associated with polymorphisms of AP0A5-1131T>C and AP0C3-482C> in chinese healthy young adults

J Lin, D Fang, J Du, S Shigdar, L Xiao, X Zhou, W Duan

(2011), Vol. 58, pp. 150-157, Annals of nutrition and metabolism, Basel, Switzerland, C1

Associations of the SREBP-1c gene polymorphism with gender-specific changes in serum lipids induced by a high-carbohydrate diet in healthy Chinese youth

Z Zhang, R Gong, J Du, L Xiao, W Duan, X Zhou, D Fang

(2011), Vol. 36, pp. 226-232, Applied physiology, nutrition and metabolism, Ottawa, Canada, C1

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies

S Shigdar, A Ward, A De, C Yang, M Wei, W Duan

(2011), Vol. 155, pp. 3-13, British journal of haematology, Oxford, U. K., C1

Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study

Y Liu, S Mo, H Bi, B Hu, C Li, Y Wang, L Huang, M Huang, W Duan, J Liu, M Wei, S Zhou

(2011), Vol. 41, pp. 259-280, Xenobiotica, London, U. K., C1

Effects of lipoprotein lipase gene variations, a high-carbohydrate low-fat diet, and gender on serum lipid profiles in healthy Chinese Han youth

X Huang, R Gong, J Lin, R Li, L Xiao, W Duan, D Fang

(2011), Vol. 5, pp. 198-204, Bioscience trends, Tokyo, Japan, C1

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule

S Shigdar, J Lin, Y Yu, M Pastuovic, M Wei, W Duan

(2011), Vol. 102, pp. 991-998, Cancer Science, Tokyo, Japan, C1-1

Aptasensors : a review

Y Lim, A Kouzani, W Duan

(2010), Vol. 6, pp. 93-105, Journal of biomedical nanotechnology, Valencia, Calif., C1

Lab-on-a-chip : a component view

Y Lim, A Kouzani, W Duan

(2010), Vol. 16, pp. 1995-2015, Microsystem technologies : sensors actuators systems integration, Heidelberg, Germany, C1

Spermatogenesis in the blue swimming crab, Portunus pelagicus, and evidence for histones in mature sperm nuclei

M Stewart, P Stewart, N Soonklang, V Linthong, P Hanna, W Duan, P Sobhon

(2010), Vol. 42, pp. 137-150, Tissue and cell, United Kingdom, C1

Disposition pathways and pharmacokinetics of herbal medicines in humans

S He, C Li, J Liu, E Chan, W Duan, S Zhou

(2010), Vol. 17, pp. 4072-4113, Current medicinal chemistry, Amsterdam, The Netherlands, C1

Aptamer therapeutics: the 21st century's magic bullet of nanomedicine

S Shigdar, J Luczo, M Wei, R Bell, A Danks, K Liu, D Wei

(2010), Vol. 1, pp. 118-124, Open conference proceedings journal, Bussum, The Netherlands, C1-1

TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults

J Du, D Fang, J Lin, L Xiao, X Zhou, S Shigdar, W Duan

(2010), Vol. 21, pp. 1114-1119, Journal of nutritional biochemistry, New York, N.Y., C1-1

GSK3β modulates PACAP-induced neuritogenesis in PC12 cells by acting downstream of Rap1 in a caveolae-dependent manner

W Zhang, A Smith, J Liu, N Cheung, S Zhou, K Liu, Q Li, W Duan

(2009), Vol. 21, pp. 237-245, Cellular signalling, Amsterdam, The Netherlands, C1

Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6

S Mo, Y Liu, W Duan, M Wei, J Kanwar, S Zhou

(2009), Vol. 10, pp. 730-753, Current drug metabolism, Hilversum, The Netherlands, C1

Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2

S Zhou, L Yang, M Wei, W Duan, E Chan

(2009), Vol. 10, pp. 713-729, Current drug metabolism, Bussum, Netherlands, C1-1

Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development

S Zhou, L Wang, Y Di, C Xue, W Duan, C Li, Y Li

(2008), Vol. 15, pp. 1981-2039, Current medicinal chemistry, Schiphol, Netherlands, C1

The C-terminus of PRK2/PKNγ is required for optimal activation by RhoA in a GTP-dependent manner

W Lim, X Chen, J Liu, B Tan, S Zhou, A Smith, N Lees, L Hou, F Gu, X Yu, Y Du, D Smith, C Verma, K Liu, W Duan

(2008), Vol. 479, pp. 170-178, Archives of biochemistry and biophysics, New York, N.Y., C1

Clincial pharmacogenetics and potential application in personalized medicine

S Zhou, Y Di, E Chan, Y Du, V Chow, C Xue, X Lai, J Wang, C Li, M Tian, W Duan

(2008), Vol. 9, pp. 738-784, Current drug metabolism, Hilversum, Netherlands, C1

Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc

D Xu, J Dwyer, L He, W Duan, J Liu

(2008), Vol. 283, pp. 23567-23580, Journal of biological chemistry, Bethesda, Md, C1

Protein kinase C isozymes as potential therapeutic targets in immune disorders

M Lee, W Duan, S Tan

(2008), Vol. 12, pp. 535-552, Expert opinion on therapeutic targets, London, England, C1

Emerging host cell targets for hepatitis C therapy

Y He, W Duan, S Tan

(2007), Vol. 12, pp. 209-217, Drug discovery today, Barking, England, C1

Sulfatide-tenascin interaction mediates binding to the extracellular matrix and endocytic uptake of liposomes in glioma cells

K Shao, Q Hou, M Go, W Duan, N Cheung, S Feng, K Wong, A Yoram, W Zhang, Z Huang, Q Li

(2007), Vol. 64, pp. 506-515, Cellular and molecular life sciences, Basel, Switzerland, C1

Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge

X Yu, S Lin, Z Zhou, X Chen, J Liang, P Liu, W Duan, B Chowbay, J Wen, S Zhou

(2007), Vol. 8, pp. 1-16, Current drug metabolism, Hilversum, The Netherlands, C1

Role of P-glycoprotein in limiting the brain penetration of glabridin, an active isoflavan from the root of Glycyrrhiza glabra.

X Yu, Z Zhou, S Lin, X Chen, X Yu, J Liang, W Duan, J Wen, X Li, S Zhou, B Chowbay, E Chan, J Cao, C Li, C Xue

(2007), Vol. 24, pp. 1668-1690, Pharmaceutical research, Delft, The Netherlands, C1

Role of the ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza

X Yu, Z Zhou, S Lin, X Chen, X Yu, J Liang, W Duan, J Wen, X Li, S Zhou

(2007), Vol. 37, pp. 375-415, Xenobiotica: the fate of foregn compounds in biological systems, Abingdon, England, C1

Simultaneous determination of irinotecan (CPT-11) and SN-38 in tissue culture media and cancer cells by high performance liquid chromatography: Application to cellular metabolism and accumulation studies

Z Hu, X Yang, X Chen, E Chan, W Duan, S Zhou

(2007), Vol. 850, pp. 575-580, Journal of chromatography. B, analytical technologies in the biomedical and life sciences, Amsterdam, Nertherlands, C1

Histological studies of the ovaries of two tropical portunid crabs, Portunus pelagicus (L.) and Scylla serrata (F.)

M Stewart, N Soonklang, P Stewart, P Hanna, W Chaitip, A Parratt, W Duan, P Sobhon

(2007), Vol. 50, pp. 85-97, Invertebrate reproduction and development, Rehovot, Israel, C1

Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells

W Zhang, W Duan, N Cheung, Z Huang, K Shao, Q Li

(2007), Vol. 103, pp. 1157-1167, Journal of neurochemistry, Chichester, England, C1

Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats

X Yu, S Lin, Z Zhou, X Chen, J Liang, W Duan, X Yu, J Wen, B Chowbay, C Li, F Sheu, E Chan, S Zhou

(2007), Vol. 417, pp. 261-265, Neuroscience letters, Limerick, Ireland, C1

Design of new oxazaphosphorine anticancer drugs

J Liang, M Huang, W Duan, X Yu, S Zhou

(2007), Vol. 13, pp. 963-978, Current pharmaceutical design, Hilversum, The Netherlands, C1

A mechanistic study on altered pharmacokinetics of irinotecan by St. Johns wort

Z Hu, X Yang, X Chen, E Chan, W Duan, M Huang, X Yu, J Wen, S Zhou, J Cao

(2007), Vol. 8, pp. 157-171, Current drug metabolism, Hilversum, The Netherlands, C1

Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimers disease, across the blood-brain

X Yu, S Lin, X Chen, Z Zhou, J Liang, W Duan, B Chowbay, J Wen, E Chan, J Cao, C Li, S Zhou

(2007), Vol. 8, pp. 365-377, Current drug metabolism, Hilversum, Netherlands, C1

Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra

J Cao, X Chen, J Liang, X-Q Yu, A-L Xu, E Chan, W Duan, M Huang, J-Y Wen, X-Y Yu, X-T Li, F-S Sheu, S-F Zhou

(2007), Vol. 35, pp. 539-553, Drug metabolism and disposition, Bethesda, Md., C1-1

The last 10 amino acid residues beyond the hydrophobic motif are critical for the catalytic competence and function of protein kinase Cá*

S Yeong, Y Zhu, D Smith, C Verma, W Lim, B Tan, Q Li, N Cheung, M Cai, Y Zhu, S Zhou, S Tan, W Duan

(2006), Vol. 281, pp. 30768-30781, Journal of biological chemistry, Bethesda, Md, C1

The very C-terminus of protein kinase CĹ is critical for the full catalytic competence but its hydrophobic motif is dispensable for the interaction with 3-phosphoinositide-dependent kinase-1

Y Zhu, D Smith, C Verma, W Lim, B Tan, J Armstrong, S Zhou, E Chan, S Tan, Y Zhu, N Cheung, W Duan

(2006), Vol. 18, pp. 807-818, Cellular signalling, Amsterdam, Netherlands, C1-1

Analysis of cardioprotective effects using purified Saliva miltiorrhiza extract on isolated rat hearts

P Chang, J Mao, S Huang, L Ning, Z Wang, T On, W Duan, Y Zhu

(2006), Vol. 101, pp. 245-249, Journal of Pharmacological Sciences, Japan, C1-1

Drug-herb interactions: eliminating toxicity with hard drug design.

X Yang, Z Hu, W Duan, Y Zhu, S Zhou

(2006), Vol. 12, pp. 4649-4664, Current pharmaceutical design, Hilversum, The Netherlands, C1-1

St. Johns wort attenuates irinotecan-induced diarhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis

Z Hu, X Yang, S Chan, A Xu, W Duan, Y Zhu, F Sheu, U Boelsterli, E Chan, Q Zhang, J Wang, P Rachel Ee, H Koh, M Huang, S Zhou

(2006), Vol. 216, pp. 225-237, Toxicology and applied pharmacology, San Diego Calif., C1-1

Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophsphamide therapy in patients with systemic lupus erythematosus

S Zhong, M Huang, X Yang, L Liang, Y Wang, M Romkes, W Duan, E Chan, S Zhou

(2006), Vol. 62, pp. 457-472, British journal of clinical pharmacology, London, England, C1-1

Intracellular drug delivery by sulfatide-mediated liposomes to gliomas

K Shao, Q Hou, W Duan, M Go, K Wong, Q Li

(2006), Vol. 115, pp. 150-157, Journal of controlled release, Amsterdam, The Netherlands, C1-1

Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese

S Guan, M Huang, E Chan, X Chen, W Duan, S Zhou

(2006), Vol. 29, pp. 14-21, European journal of pharmaceutical sciences, Amsterdam, The Netherlands, C1-1

Pharmacokinetics of recombinant human endostatin in rats

X Yang, Z Hu, E Chan, W Duan, S Zhou

(2006), Vol. 7, pp. 565-576, Current drug metabolism, Hilversum, The Netherlands, C1-1

A mechanistic study on reduced toxicity of irontecan by coadministered thalidomide, a tumor necrosis factor-a inhibitor

X Yang, Z Hu, A Xu, W Duan, Y Zhu, M Huang, F Sheu, Q Zhang, J Bian, E Chan, X Li, J Wang, S Zhou

(2006), Vol. 319, pp. 82-104, Journal of pharmacology and experimental therapeutics, Bethesda, Md., C1-1

Small interfering RNA-mediated silencing of cytochromeP450 3A4 gene

J Chen, X Yang, M Huang, Z Hu, M He, W Duan, E Chan, F Sheu, X Chen, S Zhou

(2006), Vol. 34, pp. 1650-1657, Drug metabolism and disposition, Bethesda, Md., C1-1

A mechanistic study of the intestinal absorption of crypotanshinone, the major active constituent of Saliva miltiorrhiza

J Zhang, M Huang, S Guan, H Bi, Y Pan, W Duan, S Chan, X Chen, Y Hong, S Zhou

(2006), Vol. 317, pp. 1285-1294, Journal of pharmacology and experimental therapeutics, Bethesda, Md., C1-1

Early induction of chalpains in rotenone-mediated neuronal apoptosis

M Chen, Y Yap, M Choy, C Koh, S Seet, W Duan, M Whiteman, N Cheung

(2006), Vol. 397, pp. 69-73, Neuroscience letters, Limerick, Ireland, C1-1

Nitric oxide protects against mitochondrial permeabilizastion induced by gluthathione depletion: role of S-nitrosylation?

M Whiteman, Y Chua, D Zhang, W Duan, Y Liou, J Armstrong

(2006), Vol. 339, pp. 255-262, Biochemical and biophysical research comminications, San Diego Calif., C1-1

A study of the effects of flux density and frequency on Pulsed electromagnetic field on Neurite outgrowth in PC12 cells.

Y Zhang, J Ding, W Duan

(2006), Vol. 32, pp. 1-9, Journal of biological physics: an intrnational journal for the formulation and application of physical and mathematical models in the biological sciences, Amsterdam, The Netherlands, C1-1

Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer.

X Chen, Z Hu, X Yang, M Huang, Y Gao, W Tang, S Chan, X Dai, J Ye, P Ho, W Duan, H Yang, Y Zhu, S Zhou

(2006), Vol. 6, pp. 499-508, International immumopharmacology, Barking, England, C1-1

Topotecan is a substrate for multidrug resistance associated protein 4

Q Tian, J Zhang, S Chan, T Chin Tan, W Duan, M Huang, Y Zhu, E Chan, Q Yu, Y Nie, P Chi-Liu Ho, Q Li, K Ng, H Yang, H Wei, J Bian, S Zhou

(2006), Vol. 7, pp. 105-118, Current drug metabolism, Hilversum, Netherlands, C1-1

The very C-terminus of PRK1/PKN is essential for its activation by RhoA and downstream signaling

W Lim, B Tan, Y Zhu, S Zhou, J Armstrong, Q Li, Q Dong, E Chan, D Smith, C Verma, S Tan, W Duan

(2006), Vol. 18, pp. 1473-1481, Cellular signalling, Amsterdam, Netherlands, C1-1

Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against pseudomonas aeruginosa in a systemic rat infection model

E Chan, S Zhou, S Sahasranaman, W Duan

(2006), Vol. 23, pp. 729-741, Pharmaceutical research, New York, N.Y., C1-1

A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked rats

K Loh, L Low, W Wong, S Zhou, S Huang, R Silva, W Duan, W Chou, Y Zhu

(2006), Vol. 398, pp. 28-33, Neuroscienceletters, Limerick, Ireland, C1-1

U18666A-mediated apoptosis in cultured murine cortical neurons : role of caspases, calpains and kinases

C Koh, R Qi, D Qu, A Melendez, J Manikandan, B Bay, W Duan, N Cheung

(2006), Vol. 18, pp. 1572-1583, Cellular signalling, Amsterdam, Netherlands, C1-1

Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered Thalidomide

X Yang, Z Hu, S Chan, W Duan, P Ho, U Boelsterli, K Ng, E Chan, J Bian, Y Chen, M Huang, S Zhou

(2006), Vol. 7, pp. 431-454, Current drug metabolism, Hilversum, The Netherlands, C1-1

Induction of propranolol metabolism by Ginkgo biloba extract EGb 761 in rats

L Zhao, M Huang, J Chen, P Rachel Ee, E Chan, W Duan, Y Guan, Y Hong, X Chen, S Zhou

(2006), Vol. 7, pp. 577-587, Current drug metabolism, Hilversum, The Netherlands, C1-1

Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese

S Zhong, S Zhou, X Chen, S Chan, E Chan, K Ng, W Duan, M Huang

(2006), Vol. 28, pp. 77-85, European journal of pharmaceutical sciences, Amsterdam, The Nertherlands, C1-1

Identification of an integral plasma membrane pool of protein kinase C in mammalian tissues and cells

Y Zhu, W Lim, B Tan, T Teo, W Duan

(2005), Vol. 17, pp. 1125-1136, Cellular signalling, New York, N.Y., C1-1

The PKCÁ-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals

Y Zhu, Q Dong, B Tan, W Lim, S Zhou, W Duan

(2005), Vol. 65, pp. 4520-4524, Cancer research, Philadelphia, Pa., C1-1

Metabolism and transport of oxazaphosphorines and the clinical implications

J Zhang, Q Tian, Y Sui, C Shu, S Zhou, W Duan, Y Zhu

(2005), Vol. 37, pp. 611-703, Drug metabolism reviews, Abingdon, Eng., C1-1

Effects of purified herbal extract of Saliva miltiorrhiza on ischemic rat myocardium after acute myocardial infarction

J Sun, S Huang, B Tan, M Whiteman, Y Zhu, Y Wu, Y Ng, W Duan, Y Zhu

(2005), Vol. 76, pp. 2849-2860, Life sciences, Amsterdam, The Netherlands, C1-1

The last five amino acid residues at the C-terminus of PRK1 /KKN is essential for full lipid responsiveness

W Lim, Y Zhu, C Wang, B Tan, J Armstrong, T Dockland, H Yang, Y Zhu, T Teo, W Duan

(2005), Vol. 17, pp. 1084-1097, Cellular signalling, New York, N.Y., C1-1

Prediction of herb-drug metabolic interactions: a simulation study

S Zhou, M Huang, A Xu, H Yang, W Duan, J Paxton

(2005), Vol. 19, pp. 464-471, Phytotherapy research: an international journal devoted to mekical and scientific research on plants and plant products, Chichester, England, C1-1

Simultaneous determination of the lactone and carboxylate forms of irintecan (CPT-11) and its actie metabolite SN-38 by high-performance liquid chromatography: Application to plasma pharmacokinetic studies in the rat.

X Yang, Z Hu, S Chan, B Goh, W Duan, E Chan, S Zhou

(2005), Vol. 821, pp. 221-228, Journal of chromatography. B, analytical technologies in the biomedical and life sciences, Amsterdam, The Netherlands, C1-1

Molecular characterization of Osh6p, an oxysterol binding protein homolog in the yeast Saccharomyces cerevisiae

P Wang, W Duan, A Munn, H Yang

(2005), Vol. 272, pp. 4703-4715, FEBS journal, London, England, C1-1

Influence of pulsed electromagnetic field with different pulse duty cycles on neurite outgrowth in PC12 rat pheochromocytoma cells

Y Zhang, J Ding, W Duan, W Fan

(2005), Vol. 26, pp. 406-411, Bioelectromagnetics, New York, N.Y., C1-1

Human multidrug resistance associated protein 4 resitance to camtothecins

Q Tian, J Zhang, T Tan, E Chan, W Duan, S Chan, U Boelsterli, P Ho, H Yang, J Bian, M Huang, Y Zhu, W Xiong, X Li, S Zhou

(2005), Vol. 22, pp. 1837-1853, Pharmaceutical research, New York, N.Y., C1-1

Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to actue gastrointestinal tosicity of doxorubicin

J Li, S Zhou, H Huynh, W Duan, E Chan

(2005), Vol. 22, pp. 1954-1963, Pharmaceutical research, Delft, The Netherlands, C1-1

Antitumor activity and underlying mechamisms of ganopoly, the refined polysaccharides extracted from ganodrema lucidum, in mice

Y Gao, H Gao, E Chan, W Tang, A Xu, H Yang, M Huang, J Ln, X Li, W Duan, C Xu, S Zhou

(2005), Vol. 34, pp. 171-198, Immunological investigations: a journal of molecular and cellular immunology, New York, N.Y., C1-1

Insights into exazaphosphorine resistance and possible approaches to its circumvention

J Zhang, Q Tian, S Chan, W Duan, S Zhou

(2005), Vol. 8, pp. 271-297, Drug resistance updates, Edinburgh, Scotland, C1-1

St Johns wort modulates the toxicities and parmacokinetics of CPT-11 (Irontecan) in rats

Z Hu, X Yang, P Ho, E Chan, S Chan, C Xu, X Li, Y Zhu, W Duan, X Chen, M Huang, H Yang, S Zhou

(2005), Vol. 22, pp. 902-914, Pharmaceutical research, Amsterdam, The Netherlands, C1-1

Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat

X Yang, Z Hu, S Chan, P Ho, E Chan, W Duan, B Goh, S Zhou

(2005), Vol. 39, pp. 299-304, Journal of pharmaceutical and biomedical analysis, Amsterdam, The Netherlands, C1-1

Herb-drug interactions: a literature review

Z Hu, X Yang, P Ho, S Chan, P Heng, E Chan, W Duan, H Koh, S Zhou

(2005), Vol. 65, pp. 1239-1282, Drugs, Auckland, New Zealand, C1-1

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs

S Zhou, S Chan, B Goh, E Chan, W Duan, M Huang, H McLeod

(2005), Vol. 44, pp. 279-304, Clinical pharmacokinetics, Auckland, New Zealand, C1-1

Drug bioactivation, covalent binding to target proteins and toxicity relevance

S Zhou, E Chan, W Duan, M Huang, Y Chen

(2005), Vol. 37, pp. 41-213, Drug metabolism reviews, New York, N.Y., C1-1

Inhaled p38a mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice

W Duan, J Chan, K McKay, J Crosby, H Choo, B Leung, J Karras, W Wong

(2005), Vol. 171, pp. 571-578, American journal of respiratory and critical care medicine, New York, N.Y., C1-1

Multidrug resistance proteins (MRPs) and implication in drug development

Q Tian, J Zhang, E Chan, W Duan, S Zhou

(2005), Vol. 64, pp. 1-18, Drug development research, New York, N.Y., C1-1

An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model

W Duan, A Aguinaldo Datiles, B Leung, C Vlahos, W Wong

(2005), Vol. 5, pp. 495-502, International immunopharmacology, Amsterdam, The Netherlands, C1-1

The PKCa-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals

Y Zhu, Q Dong, B Tan, W Lim, S Zhou, W Duan

(2005), Vol. 65, pp. 4520-4524, Cancer research, Philadelphia, Pa., C1-1

Novel agents that potentially inhibit irinotecan-induced diarrhea

X Yang, Z Hu, S Chan, E Chan, B Goh, W Duan, S Zhou

(2005), Vol. 12, pp. 763-771, Current medicinal chemistry, Beijing, China, C1-1

Signaling via a novel integral plasma membrane pool of a serine/threonine protein kinase PPKI in mammalian cells

Y Zhu, D Stolz, F Guo, M Ross, S Watkins, B Tan, R Qi, E Manser, Q Li, B Bay, T Teo, W Duan

(2004), Vol. 18, pp. 1722-1724, The FASEB journal : official publication of the Federation of American Societies for experimental biology, Bethesda, Md., C1-1

The influence of magnetic fields exposure on neurite outgrowth in PC12 rat pheochromocytoma cells

W Fan, J Ding, W Duan, Y Zhu

(2004), Vol. 282, pp. 325-328, Journal of magnetism and magnetic materials, Amsterdam, The Netherlands, C1-1

Cytochrome bc1 regulates the mitochondrial permeability transition by two distinct pathways

J Armstrong, H Yang, W Duan, M Whiteman

(2004), Vol. 279, pp. 50420-50428, Journal of biological chemistry, Bethesda, Md., C1-1

Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model

W Duan, J Chan, C Wong, B Leung, W Wong

(2004), Vol. 172, pp. 7053-7059, Journal of immunology, Rockville, Md., C1-1

Inhibitor of p42/44 mitogen-activated protein kinase, but not p38 MAPK, attenuated antigen challenge of guinea pig airways in vitro

S Chue, C Seow, W Duan, K Yeo, A Koh, W Wong

(2004), Vol. 4, pp. 1089-1098, International immunopharmacology, Amsterdam, The Netherlands, C1-1

Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma

W Duan, I Kuo, S Selvarajan, K Chua, B Bay, W Wong

(2003), Vol. 167, pp. 185-192, American journal of respiratory and critical care medicine, New York, N.Y., C1-1

Metallothionein 2A expression is associated with cell proliferation in breast cancer

R Jin, V Chow, P Tan, S Dheen, W Duan, B Bay

(2002), Vol. 23, pp. 81-86, Carcinogenesis, Oxford, England, C1-1

Identification of two proteins, S14 and UIP1, that interact with UCH37

T Li, W Duan, H Yang, M Lee, F Mustafa, B Lee, T Teo

(2001), Vol. 488, pp. 201-205, FEBS letters, Amsterdam, The Netherlands, C1-1

Cloning and characterization of AWP1, a novel protein that associates with serine/threonine kinase PRK1 in vivo

W Duan, B Sun, T Li, B Tan, M Lee, T Teo

(2000), Vol. 256, pp. 113-121, Gene, Amsterdam, The Netherlands, C1-1

Wallaby transthyretin

C Brack, W Duan, A Hulbert, G Schreiber

(1995), Vol. 110, pp. 523-529, Comparative biochemistry and physiology - part b: biochemistry & molecular biology, Amsterdam, The Netherlands, C1-1

Binding of thyroxine to pig transthyretin, its cDNA structure, and other properties

W Duan, S Richardson, J Kohrle, L Chang, B Southwell, P Harms, C Brack, T Pettersson, G Schreiber

(1995), Vol. 230, pp. 977-986, European journal of biochemistry, Chichester, Eng., C1-1

Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas

D Walker, W Duan, E Popovic, A Kaye, F Tomlinson, M Lavin

(1995), Vol. 55, pp. 20-23, Cancer research, Philadelphia, Pa., C1-1

Evolution of transthyretin in marsupials

W Duan, S Richardson, J Babon, R Heyes, B Southwell, P Harms, R Wettenhall, K Dziegielewska, L Selwood, A Bradley, C Brack, G Schreiber

(1995), Vol. 227, pp. 396-406, European journal of biochemistry, Chichester, Eng., C1-1

Evolution of marsupial and other vertebrate thyroxine-binding plasma proteins

S Richardson, A Bradley, W Duan, R Wettenhall, P Harms, J Babon, B Southwell, S Nicol, S Donnellan, G Schreiber

(1994), Vol. 266, pp. R1359-R1370, American journal of physiology. Regulatory, integrative and comparative physiology, Bethesda, Md., C1-1

The Expression of the Transthyretin Gene in Liver Evolved during the Radiation of Diprotodont Marsupials in Australia

S Richardson, A Bradley, W Duan, B Southwell, L Selwood, G Schreiber

(1993), Vol. 90, pp. 177-182, General and Comparative Endocrinology, New York, N.Y., C1-1

Thyroxine Transport to the Brain: Role of Protein Synthesis by the Choroid Plexus

B Southwell, W Duan, D Alcorn, C Brack, S Richardson, J Kohrle, G Schreiber

(1993), Vol. 133, pp. 2116-2126, Endocrinology, Oxford, Eng., C1-1

Transthyretin gene expression in choroid plexus first evolved in reptiles

M Achen, W Duan, T Pettersson, P Harms, S Richardson, M Lawrence, R Wettenhall, A Aldred, G Schreiber

(1993), Vol. 265, pp. R982-R989, American Journal of Physiology, Bethesda, Md., C1-1

Expression of retinol-binding protein mRNA in mammalian choroid plexus

W Duan, G Schreiber

(1992), Vol. 101, pp. 399-406, Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology, Amsterdam, The Netherlands, C1-1

Ontogenesis of transthyretin gene expression in chicken choroid plexus and liver

B SOUTHWELL, W DUAN, G TU, G SCHREIBER

(1991), Vol. 100, pp. 329-338, Comparative biochemistry and physiology part B: Comparative biochemistry, Amsterdam, The Netherlands, C1-1

Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin: implications for the evolution of structure and function of transthyretin in vertebrates Isolation, characterization, cDNA cloning and gene

W DUAN, M ACHEN, S RICHARDSON, M LAWRENCE, R WETTENHALL, A JAWOROWSKI, G SCHREIBER

(1991), Vol. 200, pp. 679-687, European journal of biochemistry, Chichester, Eng., C1-1